Quality by Design (QbD) for Biologics from a CDMO Perspective
Summary: Quality by Design (QbD) has revolutionized biologics manufacturing and quality assurance by emphasizing process understanding and design control over end-product testing. This approach helps biopharmaceutical companies speed up development, cut costs, and ensure the safety, efficacy, and quality of their products. In this executive summary, bioprocess experts demonstrate how QbD principles can be applied to overcome obstacles, achieve desired results, and deliver better biologics to patients more quickly.